Michael F. Masic

Chief Executive Officer

Visionary Leader in Capital Growth and Strategic Scaling Across Diverse Industries

Michael F. Masic iis an accomplished healthcare executive, entrepreneur, and biotechnology innovation advocate with more than 30 years of experience in the medical industry. As Chief Executive Officer of Severus Biotech and Westview Equity Partners, LLC, he brings extensive clinical expertise, strategic leadership, and a commitment to advancing innovative healthcare technologies, biotechnology research, and life sciences initiatives.

Michael holds both a Bachelor of Science in Nursing (BSN) and a Master of Science in Nursing (MSN), with a specialization in the Family Nurse Practitioner track, from Auburn University at Montgomery. His professional background encompasses cardiology, vascular health, functional medicine, metabolic health, and exercise science, providing a strong clinical foundation for evaluating emerging medical technologies and therapeutic innovations.

Throughout his career, Michael has demonstrated a passion for bridging traditional medicine with emerging biotechnology and scientific advancements. His interests include the development of innovative therapeutic solutions, personalized medicine, regenerative healthcare approaches, and the integration of naturally derived compounds into modern medical research.

A particular area of focus is the exploration of medicinal cannabis, psilocybin, and other bioactive compounds for their potential therapeutic applications. His interests include research into chronic pain management, neurological disorders, post-traumatic stress disorder (PTSD), anxiety, and other complex medical conditions. Michael advocates for evidence-based research, clinical evaluation, and responsible innovation to better understand the potential benefits of these emerging therapies.

As CEO of Westview Equity Partners, Michael provides executive leadership and strategic direction for initiatives focused on healthcare innovation, research and development, and emerging opportunities within biotechnology and life sciences. His combination of clinical knowledge and executive experience positions him to contribute to strategic partnerships involving biotechnology companies, medical research organizations, healthcare institutions, and emerging technology ventures.

Michael recognizes the importance of collaboration among scientific researchers, healthcare professionals, investors, and industry leaders in advancing biotechnology innovations from early-stage research toward potential clinical and commercial applications. His leadership philosophy emphasizes scientific integrity, patient-centered innovation, operational sustainability, and long-term value creation.

Beyond biotechnology and healthcare, Michael is a co-owner of Motion Beverages, a health-focused beverage company emphasizing natural ingredients, antioxidant-rich fruits, and wellness-oriented product development. This entrepreneurial venture reflects his broader interest in preventive health, nutrition science, and innovative consumer wellness products.

Michael is also deeply committed to community development and social impact. He actively supports initiatives designed to provide second chances for individuals affected by addiction, incarceration, and socioeconomic challenges. His dedication to rehabilitation, education, and community reintegration reflects his belief that sustainable healthcare innovation should create meaningful improvements in both individual lives and underserved communities.

With more than three decades of medical experience, advanced clinical education, and executive leadership, Michael F. Masic brings a distinctive combination of healthcare expertise, entrepreneurial vision, and strategic insight to the biotechnology and life sciences sectors. His professional mission is to help advance innovative medical solutions, support transformative research, and contribute to the development of healthcare technologies that improve patient outcomes and quality of life.

EXECUTIVE AREAS OF EXPERTISE

• Biotechnology & Life Sciences Strategy

• Healthcare Executive Leadership

• Medical Research & Development

• Clinical Medicine & Patient-Centered Care

• Cardiology & Vascular Health

• Functional Medicine & Metabolic Health

• Emerging Therapeutics & Bioactive Compounds

• Strategic Healthcare Partnerships

• Healthcare Entrepreneurship & Innovation

• Wellness Product Development